Stem Cell Transplant

Conditions and Indications

When Is It Necessary?

A stem cell transplant is a powerful, often curative treatment, but it is not suitable for every patient or every condition. It is a major medical procedure reserved for specific diseases where the potential for a cure or long-term remission outweighs the risks. At Liv Hospital, our multidisciplinary tumor board evaluates every case individually to determine if a transplant is the right path forward.

For international patients, understanding the specific indications the medical reasons to perform a transplant is the first step. Generally, a transplant is recommended when the bone marrow has failed, or when a blood cancer is aggressive, has returned after treatment (relapsed), or has a high risk of returning (high-risk features).

Which types of blood cancer are treated with stem cell transplants?

Blood cancers are the most common reason for a stem cell transplant. However, the type of transplant (Autologous vs. Allogeneic) depends on the specific disease.

1. Acute Leukemias (AML and ALL)

Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) are aggressive cancers that start in the bone marrow.

• Indication: An allogeneic transplant is often the standard of care for patients with high-risk genetic markers (like FLT3 mutation or Philadelphia chromosome) or those who do not achieve a deep remission with chemotherapy alone. It is the only potential cure for many high-risk leukemias.

2. Chronic Leukemias (CML and CLL)

Chronic Myeloid Leukemia (CML) is now often managed with targeted oral therapies (TKIs), but a transplant remains a curative option for patients who develop resistance to these drugs or progress to a “blast crisis.”

3. Lymphomas (Hodgkin and Non-Hodgkin)

For Hodgkin Lymphoma and Non-Hodgkin Lymphoma (NHL), a transplant is typically indicated if the disease returns (relapsed) after initial chemotherapy or is “refractory” (does not respond).

Indication: An autologous transplant is the standard “second-line” treatment for relapsed Diffuse Large B-Cell Lymphoma (DLBCL) and Hodgkin Lymphoma.

4. Multiple Myeloma

Multiple Myeloma is a cancer of the plasma cells.

Indication: An autologous transplant is considered the standard of care for eligible, newly diagnosed patients. While not always curative, it significantly extends survival and the period of remission.

What are the primary indications for a hematopoietic stem cell transplant?

The indications for a hematopoietic stem cell transplant (HSCT) are broadly categorized into two groups: malignant (cancerous) diseases and non-malignant (benign or genetic) disorders.

In malignant diseases, the transplant allows for the use of high-dose chemotherapy to kill cancer cells, followed by a “rescue” with new stem cells. In allogeneic transplants (using a donor), it also provides a new immune system to fight the cancer. In non-malignant diseases, the goal is to replace a faulty bone marrow factory with a healthy one.

Can stem cell transplants cure non-cancerous blood disorders?

Yes. One of the most remarkable advances in hematology is the ability to cure lifelong genetic disorders.

• Sickle Cell Disease & Thalassemia Major: These are genetic conditions where the body produces abnormal hemoglobin. An allogeneic transplant replaces the patient’s defective marrow with healthy donor marrow, effectively curing the disease and eliminating the need for lifelong blood transfusions and pain crises.
• Severe Aplastic Anemia: A condition where the bone marrow simply stops producing blood cells. For young patients with a matched sibling donor, a transplant is the treatment of choice and is often curative.
• Primary Immunodeficiency Disorders: Conditions where a child is born with a missing or broken immune system (like SCID). A transplant can build a new, functioning immune system.

What are the eligibility criteria for a transplant at Liv Hospital?

Having a condition listed above does not automatically make a patient a candidate for transplant. The patient’s body must be strong enough to withstand the “conditioning” chemotherapy. At Liv Hospital, we use rigorous international criteria to ensure safety:

• Physiological Age: While we have successfully transplanted patients over 70, the biological “fitness” is more important than chronological age.
• Organ Function: The heart, lungs, kidneys, and liver must function above a certain threshold. We use ECHO and PFT tests to confirm this.
• Performance Status: Patients should be active and able to perform daily tasks (ECOG score of 0-1 is ideal).
• Infection Status: Active, uncontrolled infections (like severe fungal pneumonia) must be treated before the transplant can begin.

For international patients, we request recent medical reports to perform a “pre-eligibility” assessment before travel.

When is a transplant considered “urgent”?

In some cases, time is critical.

• Acute Leukemia: If a patient with AML achieves remission, the “window of opportunity” for a transplant is often narrow. Delaying can allow the leukemia to return.
• Bone Marrow Failure: In severe Aplastic Anemia, the risk of fatal infection is high, making an urgent transplant necessary as soon as a donor is found.

Liv Hospital’s International Patient Center prioritizes these cases, expediting the donor search (HLA typing) and visa processes to start treatment immediately.

Diagnosis and Evaluation

The Path to a Successful Transplant

A stem cell transplant is not a procedure that is decided upon lightly. It requires a rigorous, multi-step evaluation process to ensure that the patient’s body can withstand the treatment and that the transplant offers the best chance for a cure. At Liv Hospital, this evaluation phase is the cornerstone of our success. We utilize advanced genetic testing and comprehensive organ screening to create a personalized “risk-benefit” profile for every international patient.

The diagnosis and evaluation phase answers three critical questions:

1. Is the disease sensitive to the transplant (will it work)?
2. Is the patient physically strong enough for the procedure?
3. Do we have a suitable stem cell donor?

How is the need for a transplant confirmed?

Before planning a transplant, we must confirm the exact status of the disease. A transplant is most effective when the disease is in “remission” (low levels) rather than when it is bulky and aggressive.

Key Diagnostic Tests:

• Bone Marrow Biopsy and Aspiration: This is the gold standard. We take a small sample of the bone marrow (usually from the hip) to look for cancer cells or to assess marrow failure.
• Flow Cytometry: A laser-based technology that analyzes the physical and chemical characteristics of cells in the bone marrow sample. It allows us to detect even minute amounts of leukemia cells (Minimal Residual Disease – MRD) that might be missed by a microscope.
• Cytogenetics: We examine the chromosomes of the leukemia or lymphoma cells. Specific chromosomal changes (like deletion 17p in CLL or t(9;22) in CML) tell us how aggressive the disease is and if a transplant is the only way to cure it.

What is HLA Typing and why is it critical?

For patients needing an allogeneic (donor) transplant, Human Leukocyte Antigen (HLA) typing is the most important test. HLA markers are proteins on your cells that tell your immune system which cells belong to you and which are “foreign.”

The Matching Process at Liv Hospital:

• Goal: To find a “10/10” match. The closer the match, the lower the risk of rejection or Graft versus Host Disease (GvHD).
• High-Resolution Typing: Unlike standard blood tests, we use high-resolution DNA-based typing to look at the HLA genes in extreme detail. This precision is vital for reducing post-transplant complications.
• Family Screening: We first test full siblings, as they have a 25% chance of being a perfect match.
• Unrelated Donor Search: If no sibling matches, we search international registries (like NMDP/Be The Match) using our accredited access.
• Haploidentical Options: If no full match is found, we evaluate parents or children for a “half-match” transplant using special processing technology.

How do imaging and molecular tests guide the decision?

Beyond blood work, seeing the extent of the disease is crucial. We employ advanced imaging to “stage” the patient before the transplant.

Advanced Imaging Modalities:

• PET-CT Scans: For lymphoma and multiple myeloma patients, this scan uses a radioactive sugar tracer to light up active cancer cells. A “negative” PET scan before transplant is a strong predictor of success.
• MRI (Magnetic Resonance Imaging): Used to detect subtle bone lesions in multiple myeloma or to check for iron overload in the liver and heart for thalassemia patients.

Next-Generation Sequencing (NGS): This powerful genetic test scans hundreds of genes simultaneously. It helps us find “targetable mutations” (like FLT3, IDH1, or TP53). Knowing these mutations allows us to:

1. Predict how well the transplant will work.
2. Add targeted drugs (like inhibitors) to the conditioning regimen to improve outcomes.

What does the “Pre-Transplant Evaluation” involve?

Once a donor is identified (or an autologous plan is made), the patient undergoes a “fitness” test. The high-dose chemotherapy used in conditioning puts stress on every organ, so we must ensure they are up to the task.

Organ Function Screening:

• Heart: An Echocardiogram (ECHO) and MUGA scan measure the “ejection fraction” (LVEF). A score above 50% is typically required.
• Lungs: Pulmonary Function Tests (PFTs) measure lung capacity (FEV1 and FVC) and the ability to transfer oxygen (DLCO).
• Kidneys: We check the Glomerular Filtration Rate (GFR) to ensure kidneys can flush out the chemotherapy drugs safely.

Dental Evaluation: A panoramic X-ray and exam are mandatory. Any tooth decay or gum infection must be treated before the transplant, as oral bacteria can cause life-threatening sepsis when the immune count drops.

How do doctors calculate the risk of the procedure?

At Liv Hospital, we believe in transparency. We use the HCT-CI (Hematopoietic Cell Transplantation-Comorbidity Index) score. This tool combines the patient’s age, organ function, and other health issues (like diabetes or prior infections) to predict the safety of the transplant.

• Low Score (0-2): Indicates the patient is fit and can tolerate “Myeloablative” (full intensity) conditioning, which offers the highest chance of preventing relapse.
• High Score (3+): Suggests the patient is better suited for “Reduced Intensity” (RIC) or “Non-Myeloablative” (Mini) conditioning. This approach relies more on the donor’s immune system (Graft versus Tumor effect) to fight the cancer rather than high-dose chemo.

What is the remote evaluation process for international patients?

Traveling for a transplant is a big step. To make it easier, Liv Hospital offers a “Remote Second Opinion” service.

• Document Review: You send us your pathology reports, latest blood work, and imaging discs via a secure portal.
• Tumor Board Review: Our multidisciplinary council (hematologists, radiologists, and transplant coordinators) reviews your case.
• Virtual Consultation: You meet with a transplant specialist via video call to discuss preliminary eligibility and the proposed treatment plan.
• Cost Estimate: Based on this plan, we provide a transparent cost estimate so there are no surprises upon arrival.

Treatment and Procedures

Step 1: Mobilization and Harvesting – Collecting the Life-Saving Cells

The journey begins long before the actual transplant day. The first critical phase is “harvesting” or collecting the stem cells that will later save the patient’s life.

For Autologous Patients (Self-Donor): The process starts with Mobilization. Under normal conditions, stem cells live deep inside the bone marrow and do not circulate in the blood. To get them out, we administer daily injections of a growth factor called G-CSF (Granulocyte-Colony Stimulating Factor) for 4 to 5 days. This medication stimulates the bone marrow to produce millions of stem cells and release them into the bloodstream.

Once the stem cell count in the blood is high enough, Apheresis begins.

• The Procedure: The patient is connected to a cell separator machine (Spectra Optia®) via a catheter in the arm or neck.
• The Experience: It feels similar to donating blood platelets. Blood is drawn, spun in the machine to separate the stem cells, and the remaining blood is returned to the body.
• Duration: This painless process typically takes 3 to 4 hours. The collected cells are then frozen (cryopreserved) and stored until needed.

For Allogeneic Patients (Donor): The donor undergoes the same mobilization and apheresis process. In rare cases (such as for certain pediatric conditions or aplastic anemia), we may need to harvest cells directly from the pelvic bone under anesthesia. However, 90% of transplants at Liv Hospital use the non-surgical peripheral blood method described above.

Step 2: The Conditioning Regimen – Preparing the Body

Once the cells are safely stored or the donor is ready, the patient is admitted to the transplant unit to begin the Conditioning Phase. This is often considered the most physically demanding part of the treatment.

The Purpose of Conditioning:

1. Eradicate Disease: High doses of chemotherapy (and sometimes Total Body Irradiation – TBI) are delivered to kill any remaining cancer cells in the body.
2. Suppress Immunity: For allogeneic transplants, the patient’s immune system must be temporarily suppressed so it does not attack the new donor cells.
3. Create Space: The chemotherapy clears out the old bone marrow, creating physical “room” for the new stem cells to settle and grow.

Managing Side Effects: At Liv Hospital, we use a “supportive care first” approach. We know that conditioning can cause nausea, mucositis (mouth sores), and fatigue. Therefore, we do not wait for symptoms to appear. We administer anti-nausea medications, antiviral prophylaxis, and specialized oral care protocols preventatively. Our clinical nutritionists also adjust the patient’s diet to ensure they maintain strength when eating becomes difficult.

Step 3: Day Zero – The Transplant Infusion

After the conditioning is complete, there is usually a rest day, followed by Day 0. This is the day the transplant actually happens. For patients and our medical team alike, this is a day of celebration for a second birthday.

The Infusion Process: Contrary to popular belief, the transplant is not a surgery. It takes place right in the patient’s hospital room.

• The Setup: The frozen cells (for autologous) are thawed at the bedside in a water bath, or fresh donor cells (for allogeneic) arrive from the lab.
• The Administration: The cells are infused through the central venous catheter, looking very much like a bag of blood or plasma.
• The Sensation: The process is painless. Patients are awake and can talk to their families. Some patients report a taste of “creamed corn” or garlic in their mouth during the infusion due to the preservative used in frozen cells, but this passes quickly.

The entire infusion can take anywhere from 30 minutes to a few hours, depending on the volume of cells. Once the bag is empty, the “transplant” is technically done, but the biological work is just beginning.

Step 4: The Engraftment Phase – The Waiting Game

After Day 0, the patient enters the Neutropenic Phase. This is the period where the old bone marrow has been destroyed, but the new cells haven’t started working yet. The immune system is effectively at zero.

Life in Isolation: To protect the patient during this vulnerable window, Liv Hospital utilizes specialized HEPA-filtered isolation rooms. These rooms maintain positive air pressure, ensuring that no outside air (and airborne bacteria) can enter when the door is opened.

• Daily Routine: Patients are monitored 24/7. Blood tests are taken every morning to check cell counts.
• Hygiene: Meticulous personal hygiene is enforced to prevent infection from the patient’s own skin bacteria.
• Diet: A strict “neutropenic diet” is served—all food is thoroughly cooked, and no raw fruits or vegetables are allowed to eliminate the risk of foodborne bacteria.

The Sign of Success: Usually, between Day +10 and Day +21, a miracle happens. The white blood cell count, which has been at zero, starts to rise. This is called Engraftment. It means the stem cells have successfully migrated to the bone marrow “factory” and have started the production line. The patient often feels a sudden surge in energy and well-being as their body begins to defend itself again.

Advanced Techniques: Haploidentical and Mismatched Transplants

One of the reasons international patients choose Liv Hospital is our ability to perform complex transplants when a perfect donor is not available.

Standard transplants require a 10/10 HLA match. However, using Haploidentical Transplant protocols, we can use a donor who is only a half-match (like a parent, child, or sibling).

• T-Cell Depletion Technology: We use sophisticated lab techniques to remove the specific immune cells (T-cells) from the donor graft that cause rejection, while keeping the stem cells and “fighter” cells that attack cancer.
• Post-Transplant Cyclophosphamide: A specialized drug protocol that “re-educates” the immune system to accept the half-matched cells.

This capability means that virtually every patient has a potential donor, removing the biggest barrier to life-saving treatment.

Supportive Care: Treating the Whole Person

A stem cell transplant is as much a psychological challenge as it is a physical one. Isolation can be lonely, and the fear of the unknown is real.

• Psychological Support: Our on-staff psychologists visit patients regularly to provide coping strategies and emotional support.
• Physical Therapy: Staying in bed for weeks causes muscle loss. Our physiotherapists guide patients through gentle, in-room exercises (like stationary cycling) to maintain muscle mass and lung function, which has been proven to speed up engraftment.
• Patient Concierge: For our US patients, our international team handles everything from visa extensions for family members to ordering favorite meals, ensuring the patient feels at home while far away.

Recovery and Follow-up

Your Road to Renewal

Recovery from a stem cell transplant is a marathon, not a sprint. While the “transplant day” is the medical milestone, the true healing happens in the months and years that follow. For our patients, this period is often described as a “new normal”—a time of rebuilding not just the immune system, but physical strength, mental resilience, and daily routines.

At Liv Hospital, our commitment to your health does not end when you are discharged from the ward. We understand that for international patients, the transition from our sterile isolation rooms in Istanbul back to a home environment in the US or Europe requires a structured, safety-first approach. Our “Bridge to Home” program ensures that you are empowered with the knowledge to protect your new immune system while reclaiming your life.

What is Graft versus Host Disease (GvHD) and how is it managed?

For patients who undergo an allogeneic (donor) transplant, GvHD is the most significant long-term risk. It happens when the donor’s immune cells (the graft) recognize the patient’s body (the host) as foreign and attack it.

Acute GvHD (First 100 Days):

• Symptoms: Usually appears as a red, itchy rash (often on the palms or soles), severe diarrhea, or yellowing of the skin/eyes (jaundice).

• Management: We treat this immediately with increased immunosuppressants (like steroids or tacrolimus). Early detection is key, which is why our team inspects the skin daily during the early phase.

Chronic GvHD (After Day 100):

• Symptoms: Dry eyes, dry mouth, skin tightening (scleroderma-like), or joint stiffness.

• Living with it: Mild chronic GvHD can actually be a good sign it means the “Graft-versus-Tumor” effect is active and fighting any remaining cancer. However, moderate to severe cases require long-term therapy to prevent organ damage.

What are the stages of recovery after a transplant?

Recovery is divided into three distinct phases, each with its own goals and precautions.

Phase 1: The In-Patient Phase (Days 0 to +30) This is the period of “engraftment,” where the new cells find their way to the bone marrow and start producing blood.

• Goal: Infection prevention and managing side effects like mucositis (mouth sores).
• Environment: Strict isolation in our HEPA-filtered rooms.
• Milestone: Discharge usually happens when the neutrophil count (ANC) is safe (above 500) for three consecutive days and the patient can eat and take oral medications.

Phase 2: The Out-Patient “Safe Zone” (Days +30 to +100) This is the “First 100 Days,” a critical window where the immune system is working but extremely fragile.

• Goal: Monitoring for Graft versus Host Disease (GvHD) and viral reactivation (like CMV).
• Location: International patients typically stay in a hotel or apartment near Liv Hospital during this time for weekly check-ups.
• Precautions: Wearing masks in public is non-negotiable. Crowds, public transport, and raw foods are strictly off-limits.

Phase 3: Long-Term Recovery (Day +100 to 1 Year+) The immune system slowly matures.

• Goal: Re-vaccination and return to normal activities.
• Location: Back home, coordinated with your local hematologist.
• Milestone: The removal of the central venous catheter (Hickman line) is often the first sign of returning to normalcy.

How to eat safely: The “Neutropenic Diet”

Since the gut is a major entry point for bacteria, diet plays a huge role in recovery. Until the immune system is robust (usually 6 months post-transplant), patients must follow a low-microbial (neutropenic) diet.

The Golden Rules:

1. Cook Everything: No raw meat, fish (sushi), or eggs (runny yolks). All bacteria must be killed by heat.
2. Peel It or Leave It: Raw fruits and vegetables are forbidden unless they have a thick skin you peel yourself (like bananas or oranges). No salads, berries, or unpeeled apples.
3. Water Safety: We recommend bottled or boiled water. Avoid ice from public machines.
4. Avoid Probiotics: Surprisingly, “good bacteria” in yogurt or supplements can cause infections in transplant patients. Avoid products labeled “live active cultures.”

Our clinical dietitians provide a customized “Safe Eating Guide” for every patient before discharge.

Rebuilding the body: Exercise and Physical Therapy

Fatigue is the most common complaint during the first year. The chemotherapy and weeks of bed rest cause muscle atrophy. However, “listening to your body” and resting too much can actually slow recovery.

• The “Graduated” Plan: We start with gentle stretching and walking in the hospital hallway.
• Post-Discharge: We prescribe 15-20 minutes of light aerobic activity (walking, stationary bike) twice a day.
• Bone Health: Long-term steroid use can weaken bones (osteoporosis). Weight-bearing exercises are vital to maintain bone density.
• Mental Health: Exercise is also the best medicine for “chemo brain” (mental fog) and the depression that can follow the adrenaline of the transplant process.

The Bridge to Home: Long-Term Follow-Up Program

Returning to the US or your home country is a happy moment, but it can be anxiety inducing to leave the safety net of Liv Hospital. We ensure a seamless handover.

Before You Fly Home:

• Medical Summary: You receive a comprehensive “Transplant Passport” a detailed English document listing every chemotherapy drug received, your donor’s HLA data, and your exact GvHD history.
• Doctor to Doctor Handoff: Our transplant lead contacts your local hematologist to brief them on your status and the plan for the next 6 months.

Once You Are Home:

• Telemedicine: We schedule monthly video check-ins to review your local blood tests.
• Re-Immunization: Since the transplant wipes the immune memory clean, you are essentially a “newborn.” Starting 1 year after the transplant, you will need to repeat all childhood vaccines (Polio, Measles, Tetanus, etc.). Liv Hospital provides the exact schedule for your local doctor to follow.